Areas of Expertise
Market Opportunity Assessment
Countless experience in patient- and script-based modeling. Excel guru. Known for making things very flexible so you can play around with assumptions.
I have served as the crux of my firm's expertise in immuno-oncology following clinical and market developments and assisting companies from pre-clinical partnership through go-to-market strategies. We wrote a 150 page white paper on IO and I spend much of my time attending the slew of relevant medical meetings.
Valuation & Financing
Practiced in developing DCF (discounted cash flows) models and doing NPV (net present value) assessments for products at various development stages.
- Health Sectors
- Biotech, Pharmaceuticals
Biopharma Equity Research Associate
Leerink Partners LLC | August 2013 - Current
Manager, Healthcare Strategy Consulting
Boston Healthcare Associates | September 2011 - August 2013
Straegy and business development consulting for biopharmaceutical, medical device, and diagnostic companies
Putnam Associates | September 2009 - September 2010
Strategy consulting for top-20 pharmaceutical manufacturers
Putnam Associates | June 2008 - August 2008
Duke Institute for Genome Sciences & Policy | May 2006 - September 2006
U.S. House of Representatives | May 2005 - June 2005
Center for Prostate Disease Research | May 2005 - August 2005
Published in International Journal of Oncology
B.A. | Economics, Biology
London School of Economics and Political Science
MSc | Health Economics